Aug 18, 2020 / 01:30AM GMT
Operator
Okay. Thank you for your patience, ladies and gentlemen. Good morning, ladies and gentlemen. Thank you for joining Hua Medicine's 2020 interim results investor presentation hosted by Institutional Capital Advisory, the company's Investor Relations adviser.
On the call today are Dr. Li Chen, Founder, Chief Executive Officer, Chief Scientific Officer and Chief -- and Executive Director; and Mr. George Lin, JD, Chief Financial Officer and Executive Director; Ms. Emily Yeh, Director of Corporate Finance.
Dr. Li Chen will give an overview of the company's highlights, including clinical trials and recognitions. He will also share updates regarding Hua Medicine's R&D pipeline. Mr. George Lin, JD, will go through the company's financials and analysis. Dr. Li Chen, Mr. George Lin and Ms. Emily Yeh will be available to answer your questions during the Q&A session that follows.
During the presentation, you will be able to submit your questions in written format in Zoom's chat box or Q&A channel. Alternatively, you could virtually raise your hands on Zoom for an opportunity to
Half Year 2020 Hua Medicine Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot